MADRIGAL PHARMACEUTICALS, INC. | Business Contracts

Form of Restricted Stock Unit Agreement under Amended 2015 Stock Plan (Filed With SEC on February 23, 2023)

Description of Securities of the Registrant (Filed With SEC on February 23, 2023)

Sales Agreement, dated June 1, 2021, by and between Madrigal Pharmaceuticals, Inc. and Cowen and Company, LLC (Filed With SEC on June 1, 2021)

Non-Employee Director Equity Compensation Policy (Filed With SEC on May 6, 2021)

Office lease entered into as of January 10, 2019 with Four Tower Bridge Associates, a Pennsylvania Limited Partnership (Filed With SEC on May 8, 2019)

Loan and Security Agreement, dated May 9, 2022, as amended by the First Amendment to Loan and Security Agreement, dated February 3, 2023, by and among Madrigal Pharmaceuticals,... (Filed With SEC on February 9, 2023)

Form of Tranche 2 Warrant Agreement, dated February 3, 2023, by and among Madrigal Pharmaceuticals, Inc. and Hercules Capital, Inc. and affiliates (Filed With SEC on February 9, 2023)

Amendment No. 2, dated December 22, 2022, to Securities Purchase Agreement, dated June 20, 2017, by and among Madrigal Pharmaceuticals, Inc. and the investors listed on the... (Filed With SEC on December 23, 2022)

Securities Purchase Agreement, dated December 21, 2022, by and among Madrigal Pharmaceuticals, Inc. and the institutional investors listed on the signature pages thereto (Filed With SEC on December 23, 2022)

Loan and Security Agreement, dated May 9, 2022, by and among Madrigal Pharmaceuticals, Inc., Canticle Pharmaceuticals, Inc., the several banks and other financial institutions or... (Filed With SEC on August 4, 2022)

Form of Warrant Agreement, dated May 9, 2022, between Madrigal Pharmaceuticals, Inc. and Hercules Capital, Inc. and affiliates (Filed With SEC on August 4, 2022)

Sales Agreement, dated November 5, 2020, by and between Madrigal Pharmaceuticals, Inc. and Cowen and Company, LLC (Filed With SEC on November 5, 2020)

Form of Nonqualified Stock Option Agreement for Directors under Amended 2015 Stock Plan (Filed With SEC on August 6, 2020)

Description of Securities of the Registrant (Filed With SEC on February 26, 2020)

Underwriting Agreement, dated December 10, 2019, by and among Madrigal Pharmaceuticals, Inc., the Selling Stockholders, and Goldman Sachs & Co. LLC (Filed With SEC on December 12, 2019)

MADRIGAL PHARMACEUTICALS, INC. (15)